+44 1665 608 300
We are a multi-service Contract Development and Manufacturing Organisation (CDMO), serving global pharmaceutical and biotechnology companies.
The extensive experience we gained working for over 20 years as part of one of the top 5 pharma companies has given us a unique insight into fulfilling client needs. Our wide range of services can support clients across the drug development pathway and includes expertise in drug substance synthesis and manufacturing scale up, drug product manufacture, bioanalytical services and radiolabelling synthesis.
We combine agility with flexibility to provide an innovative approach to the development and manufacture of pharmaceutical products. Our ambition is to save our clients valuable time, enabling them to rapidly bring life-changing medicines to market.
We help clients take their ideas for novel drugs through the clinical steps required to prove that a new medicine is effective and safe for use. Our state-of-the-art facility permits a wide range of specialist services for integrated end-to-end solutions. By combining services, we can remove the time delay caused by a large chain of suppliers. The teams at Arcinova are based on the same site, allowing them to efficiently work together to ensure that each drug substance or drug product passes through development stages quickly. We are also highly adaptable, providing bespoke services for customers who need to overcome specific challenges.
The US Food and Drug Administration (FDA) has issued draft guidance for industry on the use of physiologically based pharmacokinetic (PBPK) analyses for biopharmaceutics applications.https://t.co/eNyl4hlGmg— Arcinova (@ArcinovaUK) October 23, 2020
This year our #WearItPink day has been a little bit different at #Arcinova— Arcinova (@ArcinovaUK) October 23, 2020
Thank you to our amazing staff for taking part and raising money for #BreastCancerNow.
Here are some pictures of the day! pic.twitter.com/NPwp98ntOK